InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,431.60
(
0.15%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.79
(
1.05%
)
Bitcoin
65,171.10
(
-1.98%
)
Post# of 5675
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

octagramt

Send PM Follow Ignore
Followers 7
Posts 599
Boards Moderated 0
Alias Born 12/23/2009

octagramt

Re: cyclone101 post# 2460

Saturday, 03/20/2010 7:21:04 PM

Saturday, March 20, 2010 7:21:04 PM

Post# of 5675
I read taht with Orphan Drug designationt, the FDA may not require Phase III clinical trials since 1000 may not be available. I'm trying to find some sources other than Wiki and About to verify this.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYTH News
More CYTH News
InvestorsHub NewsWire

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!